CYTOKINETICS INC (CYTK)

↓ Download CSV

CIK 0001061983 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

In fiscal 2025, CYTOKINETICS INC reported revenue of $88.04M, up 376.6% from the prior year. The company ran a net loss, with a net margin of -891.6%. It held $1.42B in total assets against $2.08B in total liabilities.

Key ratios (FY2025)

-695.4%
Operating margin
-891.6%
Net margin
+376.6%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$88.04M$18.47M$7.53M$94.59M$70.43M$55.83M$26.87M$31.50M$13.37M
Operating Income-$612.26M-$536.25M-$496.20M-$324.20M-$186.31M-$93.94M-$98.87M-$88.92M-$113.40M$18.69M
Net Income-$784.96M-$589.53M-$526.24M-$388.95M-$215.31M-$127.29M-$121.69M-$106.29M-$127.79M$16.45M
EPS (Diluted)$-6.54$-5.26$-5.45$-4.33$-2.80$-1.97$-2.59$0.39
Total Assets$1.42B$1.40B$824.32M$1.01B$841.32M$533.80M$289.81M$211.18M$294.81M$170.14M
Total Liabilities$2.08B$1.54B$1.21B$1.12B$597.46M$420.42M$300.75M$185.24M$184.97M$75.78M
Shareholders' Equity-$659.62M-$135.37M-$386.32M-$107.90M$243.86M$113.38M-$10.94M$25.93M$109.84M$94.36M
Cash & Equivalents$122.52M$94.86M$113.02M$65.58M$112.67M$82.98M$36.43M$42.26M$125.21M$66.87M
Operating Cash Flow-$510.01M-$395.89M-$414.33M-$299.52M-$142.52M$8.94M-$90.91M-$101.22M-$101.76M
Capital Expenditures$24.81M$3.91M$1.42M$11.34M$48.87M$11.05M$2.62M$889.0K$2.88M$1.60M
Shares Outstanding122.94M118.21M101.64M94.83M84.80M71.02M59.17M54.72M53.96M40.65M